Entrepreneurship, Healthcare, and Capitalism with Dutch Rojas of Physician Capital, Inc. 2-17-25

In this episode, Scott Becker speaks with Dutch Rojas, Founder & CEO of Physician Capital, Inc. Dutch shares his journey in healthcare entrepreneurship, his passion for price transparency, and his work in helping physicians build equity through innovative financial strategies.
KKR and Carlyle Group 2-17-25

In this episode, Scott Becker discusses how major private equity firms like KKR and Carlyle Group are adapting to tougher exit conditions.
5 Stories We Are Following Today 2-17-25

In this episode, Scott Becker breaks down five key business news stories stories,
Unlocking AI’s Potential in Healthcare and Early-Stage Investing with Venkat Mocherla 2-16-25

In this episode, host Scott Becker sits down with Venkat Mocherla, Founder of Midstream Health, to discuss the evolving role of AI in healthcare, key trends in early-stage investing, and the transformative impact of AI-driven automation on clinicians, administrators, and patients.
Private Equity Exits and the Evolving Role of Family Offices with Matt Wolf of RSM 2-15-25

In this episode, recorded live, Matt Wolf, Healthcare Senior Analyst and National Healthcare Business Valuation Leader at RSM, joins Scott Becker to discuss the shifting exit environment in private equity.
Tempus AI & Private Jets 2-15-25

n this episode, Scott Becker highlights the impressive 150% year-to-date rise of Tempest AI, founded by a financial genius and Illinois’ wealthiest resident.
Hanes Underware 2-15-25

In this episode, Scott Becker discusses Hanes’ surprising 18.5% stock drop.
5 Key Stocks to Watch 2-15-25

In this episode, Scott Becker breaks down the latest movements of five key stocks.
Tempus AI, Eli Lilly & SoundHound: 3 Stocks from One of Our Favorite Stock Pickers 2-14-25

In this episode, Scott Becker discusses three stocks chosen by one of his favorite stock pickers.
Crocs Surge 24% 2-14-25

In this episode, Scott Becker takes a lighthearted look at Crocs’ unexpected 24% stock surge.